Cargando…

Elevated ATP via enhanced miRNA-30b, 30c, and 30e downregulates the expression of CD73 in CD8(+) T cells of HIV-infected individuals

CD8(+) T cells play a crucial role against chronic viral infections, however, their effector functions are influenced by the expression of co-stimulatory/inhibitory receptors. For example, CD73 works with CD39 to convert highly inflammatory ATP to adenosine. However, its expression on T cells in the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shahbaz, Shima, Okoye, Isobel, Blevins, Gregg, Elahi, Shokrollah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947394/ https://www.ncbi.nlm.nih.gov/pubmed/35325005 http://dx.doi.org/10.1371/journal.ppat.1010378

Ejemplares similares

Sex Matters: Physiological Abundance of Immuno-Regulatory CD71+ Erythroid Cells Impair Immunity in Females
por: Mashhouri, Siavash, et al.
Publicado: (2021)

Selective Upregulation of CTLA-4 on CD8(+) T Cells Restricted by HLA-B*35Px Renders them to an Exhausted Phenotype in HIV-1 infection
por: Elahi, Shokrollah, et al.
Publicado: (2020)

Coinhibitory Receptor Expression and Immune Checkpoint Blockade: Maintaining a Balance in CD8(+) T Cell Responses to Chronic Viral Infections and Cancer
por: Okoye, Isobel S., et al.
Publicado: (2017)

Plasma Extracellular Vesicles Enhance HIV-1 Infection of Activated CD4(+) T Cells and Promote the Activation of Latently Infected J-Lat10.6 Cells via miR-139-5p Transfer
por: Okoye, Isobel, et al.
Publicado: (2021)

CD30-Positive Extracellular Vesicles Enable the Targeting of CD30-Negative DLBCL Cells by the CD30 Antibody-Drug Conjugate Brentuximab Vedotin
por: Lobastova, Liudmila, et al.
Publicado: (2021)

CD30 expression by CD8+ T cells producing type 2 helper cytokines. Evidence for large numbers of CD8+CD30+ T cell clones in human immunodeficiency virus infection
Publicado: (1994)

Brentuximab Vedotin in CD30+ Lymphomas
por: Perini, Guilherme Fleury, et al.
Publicado: (2013)

Characterization of CD30/CD30L(+) Cells in Peripheral Blood and Synovial Fluid of Patients with Rheumatoid Arthritis
por: Barbieri, Alessandro, et al.
Publicado: (2015)

Anti-CD30 chimeric antigen receptor T cell therapy for relapsed/refractory CD30(+) lymphoma patients
por: Wang, D., et al.
Publicado: (2020)

Patient-reported outcomes in CD30-directed CAR-T cells against relapsed/refractory CD30+ lymphomas
por: Tschernia, Nicholas P, et al.
Publicado: (2023)

Skin CD30(+) T cells and circulating levels of soluble CD30 are increased in patients with graft versus host disease
por: Amedei, Amedeo, et al.
Publicado: (2013)

Atorvastatin downregulates co-inhibitory receptor expression by targeting Ras-activated mTOR signalling
por: Okoye, Isobel, et al.
Publicado: (2017)

MicroRNA-30a regulates cell proliferation and tumor growth of colorectal cancer by targeting CD73
por: Xie, Minghao, et al.
Publicado: (2017)

Letter of intent, CERN-SPSC-I-73-30
por: CERN. Geneva. SPS Experiments Committee
Publicado: (1973)

Diffuse skin hyperpigmentation in CD30+ lymphoproliferation
por: Prka, Zeljko, et al.
Publicado: (2012)

Autologous stem cell transplantation in tandem with Anti-CD30 CAR T-cell infusion in relapsed/refractory CD30(+) lymphoma
por: Zhang, Peiling, et al.
Publicado: (2022)

CD71(+) erythroid suppressor cells impair adaptive immunity against Bordetella pertussis
por: Namdar, Afshin, et al.
Publicado: (2017)

Expanded antigen-experienced CD160(+)CD8(+)effector T cells exhibit impaired effector functions in chronic lymphocytic leukemia
por: Bozorgmehr, Najmeh, et al.
Publicado: (2021)

High soluble CD30, CD25 and IL-6 may identify patients with worse survival in CD30+ cutaneous lymphomas and early mycosis fungoides
por: Kadin, Marshall E., et al.
Publicado: (2011)

A novel tetravalent bispecific TandAb (CD30/CD16A) efficiently recruits NK cells for the lysis of CD30(+) tumor cells
por: Reusch, Uwe, et al.
Publicado: (2014)

Single-Fraction Radiotherapy for CD30(+) Lymphoproliferative Disorders
por: Gentile, Michelle S., et al.
Publicado: (2015)

Brentuximab vedotin: targeting CD30 as standard in CTCL
por: Prince, H. Miles, et al.
Publicado: (2018)

CD30(+) lymphomatoid skin toxicity secondary to ipilimumab
por: Bush, Amelia E., et al.
Publicado: (2020)

The Polyvalent Role of CD30 for Cancer Diagnosis and Treatment
por: Dumitru, Adrian Vasile, et al.
Publicado: (2023)

CD71(+) erythroid cells suppress T-cell effector functions and predict immunotherapy outcomes in patients with virus-associated solid tumors
por: Bozorgmehr, Najmeh, et al.
Publicado: (2023)

Cerebrospinal fluid soluble CD30 elevation despite suppressive antiretroviral therapy in individuals living with HIV-1
por: Peluso, Michael J, et al.
Publicado: (2020)

CD30 on extracellular vesicles from malignant Hodgkin cells supports damaging of CD30 ligand-expressing bystander cells with Brentuximab-Vedotin, in vitro
por: Hansen, Hinrich P., et al.
Publicado: (2016)

Conjugation of DM1 to anti-CD30 antibody has potential antitumor activity in CD30-positive hematological malignancies with lower systemic toxicity
por: Shen, Yijun, et al.
Publicado: (2019)

A new immunotherapy strategy targeted CD30 in peripheral T-cell lymphomas: CAR-modified T-cell therapy based on CD30 mAb
por: Wu, Yang, et al.
Publicado: (2021)

Depletion of polyfunctional CD26(high)CD8(+) T cells repertoire in chronic lymphocytic leukemia
por: Bozorgmehr, Najmeh, et al.
Publicado: (2023)

CD3+, CD56+, CD4−, CD8−, CD20−, CD30− Peripheral T-Cell Non-Hodgkin's Lymphoma: A Rare Case Report
por: Jagati, Ashish, et al.
Publicado: (2017)

Study of the expression of CD30 in pterygia compared to healthy conjunctivas
por: Garfias, Yonathan, et al.
Publicado: (2009)

Challenges of driving CD30-directed CAR-T cells to the clinic
por: Grover, Natalie S., et al.
Publicado: (2019)

Better method for detection of CD30: Immunohistochemistry or flow cytometry?
por: Higashi, Morihiro, et al.
Publicado: (2021)

Genomic Analysis of Cutaneous CD30-Positive Lymphoproliferative Disorders
por: Abdulla, Farah R., et al.
Publicado: (2021)

Differential transcriptional and functional properties of regulatory T cells in HIV‐infected individuals on antiretroviral therapy and long‐term non‐progressors
por: Shahbaz, Shima, et al.
Publicado: (2021)

TB granuloma: CD30 co-stimulation for CD4(+) T cell co-operation
por: Gress, Abigail R., et al.
Publicado: (2023)

Anti-PD-1 Therapy Enhances the Efficacy of CD30-Directed Chimeric Antigen Receptor T Cell Therapy in Patients With Relapsed/Refractory CD30+ Lymphoma
por: Sang, Wei, et al.
Publicado: (2022)

CD71(+)VISTA(+) erythroid cells promote the development and function of regulatory T cells through TGF-β
por: Shahbaz, Shima, et al.
Publicado: (2018)

Adult T-cell leukemia/lymphoma following elevation of serum levels of soluble cytokine receptors, sCD25 and sCD30
por: Takemoto, Shigeki, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_uv7r9lrhmp8v2j4m5rkjk49vgg